205 related articles for article (PubMed ID: 16288477)
1. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
2. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.
Cartegni L; Krainer AR
Nat Genet; 2002 Apr; 30(4):377-84. PubMed ID: 11925564
[TBL] [Abstract][Full Text] [Related]
3. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
4. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
5. Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes.
Hobson GM; Huang Z; Sperle K; Sistermans E; Rogan PK; Garbern JY; Kolodny E; Naidu S; Cambi F
Hum Mutat; 2006 Jan; 27(1):69-77. PubMed ID: 16287154
[TBL] [Abstract][Full Text] [Related]
6. Subtle discrepancies of SF2/ASF ESE sequence motif among human tissues: A computational approach.
Siala O; Rebai A; Baklouti F; Fakhfakh F
Comput Biol Chem; 2010 Jun; 34(3):203-9. PubMed ID: 20637698
[TBL] [Abstract][Full Text] [Related]
7. PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes.
Wang E; Dimova N; Cambi F
Nucleic Acids Res; 2007; 35(12):4164-78. PubMed ID: 17567613
[TBL] [Abstract][Full Text] [Related]
8. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
Liu X; Mayeda A; Tao M; Zheng ZM
J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
[TBL] [Abstract][Full Text] [Related]
9. ASF/SF2 and SC35 regulate the glutamate receptor subunit 2 alternative flip/flop splicing.
Crovato TE; Egebjerg J
FEBS Lett; 2005 Aug; 579(19):4138-44. PubMed ID: 16023113
[TBL] [Abstract][Full Text] [Related]
10. A missense mutation in the APC tumor suppressor gene disrupts an ASF/SF2 splicing enhancer motif and causes pathogenic skipping of exon 14.
Gonçalves V; Theisen P; Antunes O; Medeira A; Ramos JS; Jordan P; Isidro G
Mutat Res; 2009 Mar; 662(1-2):33-6. PubMed ID: 19111562
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation status of the Kep1 protein alters its affinity for its protein binding partner alternative splicing factor ASF/SF2.
Robard C; Daviau A; Di Fruscio M
Biochem J; 2006 Nov; 400(1):91-7. PubMed ID: 16834570
[TBL] [Abstract][Full Text] [Related]
12. The effect of disease-associated HRPT2 mutations on splicing.
Hahn MA; McDonnell J; Marsh DJ
J Endocrinol; 2009 Jun; 201(3):387-96. PubMed ID: 19332451
[TBL] [Abstract][Full Text] [Related]
13. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
14. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
[TBL] [Abstract][Full Text] [Related]
15. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.
Smith PJ; Zhang C; Wang J; Chew SL; Zhang MQ; Krainer AR
Hum Mol Genet; 2006 Aug; 15(16):2490-508. PubMed ID: 16825284
[TBL] [Abstract][Full Text] [Related]
16. Distribution of exonic splicing enhancer elements in human genes.
Wu Y; Zhang Y; Zhang J
Genomics; 2005 Sep; 86(3):329-36. PubMed ID: 16005179
[TBL] [Abstract][Full Text] [Related]
17. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.
Liu HX; Chew SL; Cartegni L; Zhang MQ; Krainer AR
Mol Cell Biol; 2000 Feb; 20(3):1063-71. PubMed ID: 10629063
[TBL] [Abstract][Full Text] [Related]
18. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
Gao H; Gordon-Kamm WJ; Lyznik LA
Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
[TBL] [Abstract][Full Text] [Related]
19. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
[TBL] [Abstract][Full Text] [Related]
20. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]